In addition, the expression of α-SMA and COL 1α1, the typical markers of liver fibrosis, was markedly decreased in the HSTP1-Exos-treated group compared with the Blank-Exos- and Lamp2b-Exos-treated groups (Fig. 7E–G). This evidence concerns the gene ACTA1 and Hepatic fibrosis.